Sep 26, 2017

Apple, Fitbit and Samsung part of FDA trial aimed at speeding tech development

AP file photo

Some of the biggest names in tech and health care are taking part in a pilot program from the FDA that looks to make it easier for companies looking to offer technology approaches to issues that fall under the agency's purview.

Why it matters: A lot of tech companies have been focusing on relatively modest products in the "wellness" space rather than more ambitious efforts that require cumbersome and time-consuming regulatory approval.

"We need to modernize our regulatory framework so that it matches the kind of innovation we're being asked to evaluate, and helps foster beneficial technology while ensuring that consumers have access to high-quality, safe and effective digital health devices," FDA Commissioner Scott Gottlieb said in a statement. "These pilot participants will help the agency shape a better and more agile approach toward digital health technology that focuses on the software developer rather than an individual product."

Who's in: Apple, Fitbit, Verily (the health unit of Google parent Alphabet), Samsung, Roche, Johnson & Johnson, Pear Therapeutics, Tidepool and Phosphorus.

How it works: The program looks to those with a proven process in place to make it easier for the companies to more quickly create new products and update existing ones.

Go deeper

Coronavirus updates: First case in sub-Saharan Africa confirmed

Data: The Center for Systems Science and Engineering at Johns Hopkins, the CDC, and China's Health Ministry. Note: China numbers are for the mainland only and U.S. numbers include repatriated citizens.

Nigeria confirmed its first novel coronavirus case in an Italian who flew to Lagos from Milan — the first known case in sub-Saharan Africa. The World Health Organization has been working to prepare Africa's health care systems to be ready for the outbreak, which is now also confirmed in Algeria and Egypt.

The big picture: COVID-19 has killed more than 2,850 people and infected over 83,700 others in some 50 countries and territories. The novel coronavirus is now affecting every continent but Antarctica, and the WHO said Wednesday the number of new cases reported outside China has exceeded those inside the country for the first time.

Go deeperArrowUpdated 51 mins ago - Health

Ad spending on 2020 primary tops $1 billion

Illustration: Aïda Amer/Axios

Spending on the 2020 presidential primary has officially surpassed the $1 billion mark, with more than half of that total coming from billionaire Michael Bloomberg, according to data from Advertising Analytics.

Why it matters: It's the most money that has been spent this early on in an election cycle in U.S. history.

The growing coronavirus recession threat

Illustration: Aïda Amer/Axios

In just a matter of weeks, top economists and investment bank analysts have gone from expecting the coronavirus outbreak to have minimal impact on the U.S. economy to warning that an outright recession may be on the horizon.

What's happening: The spread of confirmed coronavirus cases in Europe, the Middle East and the U.S., and the speed at which they are being discovered has set the table for the outbreak to have a larger and much costlier impact.